Patients with high-risk prostate cancer who had a higher dose of radiation plus long-term androgen deprivation therapy tended to live longer than those who had a lower dose.
Adding higher dose radiation led to long-term ADT led to better progression-free, cancer-specific, and overall survival vs standard-dose radiation in men with high-risk prostate cancer.